Other Treatments

SomnusNooze Articles > Treatments > Other Treatments

July 16, 2019
In Current Actions, HF Announcements, HF News, Idiopathic Hypersomnia, In Case You Missed It!, Other Treatments, Raising Awareness, Research Award Program, Research Studies Articles, Side Effects, Take Action!
By Hypersomnia Foundation

In Case You Missed It! – July 2019

Keep up to date with the news we’ve shared via social media in this month’s “In Case You Missed It!” URGENT: Health authorities warn that modafinil may cause fetal harm. CONGRATULATIONS: Dr. Caroline Maness of Emory University is the first recipient of the Hypersomnia Foundation’s...

Continue Reading
July 18, 2017
In HF News, Other Treatments, Research Studies Articles, Take Action!
By Hypersomnia Foundation

Arise Clinical Trial

CLINICAL TRIAL ENROLLING PATIENTS WITH IDIOPATHIC HYPERSOMNIA AND NARCOLEPSY TYPE 2 Balance Therapeutics is evaluating an investigational new drug BTD-001, to treat excessive daytime sleepiness in individuals diagnosed with idiopathic hypersomnia (IH) or narcolepsy type 2 (Na-2). A Phase 2 clinical trial is currently enrolling Na-2 subjects at 26...

Continue Reading
January 19, 2016
In Journal Article Summaries, Narcolepsy, Other Treatments
By Hypersomnia Foundation

Summary of Rationale Behind and Research Studies into L-carnitine as a Treatment for Narcolepsy

Background In this 2013 study published in PLoS One, the researchers Miyagawa et al hypothesized that L-carnitine supplementation might help improve narcolepsy symptoms by increasing β-fatty-acid oxidation. Fatty acids are a major energy source for the human body. For them to be broken down and metabolized via oxidation...

Continue Reading
December 22, 2015
In HF News, Narcolepsy, Other Treatments
By Hypersomnia Foundation

EMA Recommends Approval of Pitolisant for the Treatment of Narcolepsy

On November 20, 2015, the European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended that Bioprojet Pharma's drug pitolisant (Wakix) be approved for the treatment of narcolepsy with or without cataplexy. In making its recommendation, the Committee reviewed data from four studies of pitolisant—two placebo-controlled...

Continue Reading

Get SomnusNooze, our monthly e-newsletter

Sign up to receive HF updates, news from the world of sleep research, first-person stories, and more.

You will receive an email from info@hypersomniafoundation.org (please check your junk/spam folder if needed) to confirm your subscription to our newsletter through MailChimp. You are not subscribed until you confirm. Thank you for your interest in Hypersomnia Foundation!

Hypersomnia Foundation

The Hypersomnia Foundation is a tax-exempt organization as set forth in Section 501(c)(3) of the Internal Revenue Code. Its Tax ID number (EIN) is 46-4162735.

Donate

Your tax deductible gift in any amount helps support our efforts to advocate for more research, better treatments, and, ultimately, a cure for IH.

Donate

You can also support the Hypersomnia Foundation when you shop with Amazon Smile. »

Couldn't connect with Twitter

Contact Us


Hypersomnia Foundation
4514 Chamblee Dunwoody Road #229
Atlanta, GA 30338

Get Our Brochure

Copyright © 2019 Hypersomnia Foundation. All rights reserved.  |  Disclaimer